SP100 and pancreatic adenocarcinoma: Furthermore, we proposed plausible mechanisms through which SP100 family members contribute to the initiation and advancement of PAAD, incorporating perspectives such as gene variation, gene enrichment, gene coexpression, protein interactions, and drug sensitivity.